Q2 FY26 results: revenue up 26%, PAT jumps 45% YoY

Revenue Growth 20pctPat Growth 25pctNegative Operating CashflowResults View source PDF Explain this filing

LAXMIDENTL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.5%Reaction day

₹341.00

prior close

₹320.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-7.4% vs market

Medical Equipment & Supplies peers, median of 14sector-0.9%-5.5% vs sector

On the reaction day the stock moved 7.4 pts less than Nifty Microcap 250 and 5.5 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+1.5

15m

+2.1

30m

+1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.5+0.9-7.4-0.9-5.5

Next day

-8.2+0.8-9.0-2.5-5.7

-8.6+0.7-9.3-2.7-5.8

-10.3+1.3-11.6-4.3-6.0

-11.1+0.5-11.7-5.1-6.1

-14.1+0.4-14.4-5.1-9.0

-13.5-1.5-12.0-6.4-7.1

15d

-26.9-2.4-24.4-3.9-23.0

-21.4-4.4-17.0-2.2-19.3

-27.9-7.2-20.6-13.9-13.9

-40.6-5.0-35.6-24.3-16.2

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 14Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Laxmi Dental reported Q2 FY26 consolidated revenue of Rs 722.65M, up 26.5% YoY from Rs 571.19M. PAT rose 45% to Rs 85.32M from Rs 58.95M. Standalone sales grew 29% to Rs 537.75M with PAT at Rs 65.70M. H1 consolidated revenue was Rs 1,378.62M, up 18%. Laboratory segment drove growth at Rs 499.7M. Operating cash flow turned negative at around Rs -173M vs positive Rs 133M last year. Rs 640M of IPO proceeds remain unutilized. Auditor MSKA gave an unmodified review.

Likely market impact

Strong quarterly growth in revenue and profit, but watch negative operating cash flow and large unutilized IPO funds pending deployment.